FT US Pharma and Biotech Summit 2027

The FT US Pharma and Biotech Summit 2027 focuses on strategic, technological, and regulatory transformation in the pharmaceutical and biotechnology sectors, emphasizing personalized medicine, data-driven innovation, pricing, and evolving business models in healthcare.

Key Topics

• Delivering on the potential of personalised medicine: Advanced cell and gene therapies
• Drug pricing in the US
• Digital therapeutics: Competition or collaboration?
• Securing the future: Disrupting the pharma business model
• Advances in analytics: Applications at the heart of pharma
• A new era of patient-owned data: What does it mean for pharma?

Who should Attend

Senior attendees from:

• CROs
• Pharmaceuticals, biotechnology, generic pharmaceutical companies, pharmacies, pharmaceutical wholesalers
• Pharmaceutical regulators
• Healthcare insurers and government payers
• Digital health companies
• Government healthcare departments and agencies
• IT, big data and analytics providers
• Genomics and personalized medicine experts
• Diagnostic and medical devices
• Health economists
• Life science and healthcare lawyers and management consultants
• Life Science and Healthcare investment bankers, private equity and venture capitalists
• Patient representatives and health-related NGOs